Skip to content

Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies

Screening and identification of peripheral blood biomarkers in patients with COVID-19 infection based on multiomics studies

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030771
Enrollment
Unknown
Registered
2020-03-14
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:Clinical outcome
on&#32
genomics,&#32
and&#32
epigenomics&#32
to&#32
markers&#32
in&#32
peripheral&#32
blood&#32
of&#32
patients&#32
with&#32

Sponsors

The Second Xiangya Hospital of CSU
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients with COVID-19 infection that meet the diagnostic criteria of "the 5th edition Pneumonitis diagnosis and treatment guideline for COVID-19 infection of China"; 2. Age- and sex-matched normal people and patients with influenza A and B.

Exclusion criteria

Exclusion criteria: 1. Patients who are using warfarin or with bleeding disorders or bleeding tendencies; 2. Those who refuse to sign the informed consent;

Design outcomes

Primary

MeasureTime frame
RNA;DNA;

Countries

China

Contacts

Public ContactQianjin Lu

The 2nd Xiangya Hospital of CSU

qianlu5860@gmail.com+86 731-85295860

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026